Conducting cardiovascular disease research and community engaement: The Jackson heart study experience
Methods: Exams include medical history, physical examination, blood/urine analytes and interview questions on areas such as: physical activity; stress, coping and spirituality; racism and discrimination; socioeconomic position; access to health care; Annual Follow-up and cohort surveillance. Scientists and investigators are invited to publish articles that use JHS data and to disseminate and communicate study results to the broader community. The scientific writing process is managed, reviewed, and approved by the JHS Publications and Presentations Sub-Committee (P&P). Community Partnership/Outreach includes; providing avenues to reduce health disparities; exposing/engaging students in health disparities discussions; and regular community gatherings.
Results: Selected CVD indicators are: BMI = 31.75; Glucose = 99.98; Diabetes Status =18.79%; Hypertension Status = 37.10%; Fasting LDL Cholesterol (mg/dl) = 126.66; Fasting HDL Cholesterol (mg/dl) = 51.77; Fasting TCL (mg/dl) =199.30; Fasting Triglyceride Level (mg/dl) = 06.10.
Discussion: The JHS employs innovative strategies to engage the public and the scientific community.
Learning Areas:Chronic disease management and prevention
Clinical medicine applied in public health
Public health or related research
Describe the preliminary data on the health status of African Americans in the Jackson Heart Study. Discuss the development and impact of community engagement activities in the Jackson Heart Study that facilitated recruitment and retention. Explain the Jackson Heart Study processes for accessing the data for research and the development and submission of manuscript proposals
Keyword(s): Heart Disease, Epidemiology
Qualified on the content I am responsible for because: I am a senior researcher in cardiovascular disease and diabetes studies.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.